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Background: Oral cancer associated with high risk (HPV-HR) human papilloma virus (HPV) has been increas-
ing. HPV-HR has been associated with epithelial dysplasia, however, little information exists on its frequency in 
epithelial hyperplasia lesions. The aim of this study is to compare HPV genotypes in dysplastic and hyperplastic 
lesions of oral cavity.
Material and Methods: Two hundred and fifty oral lesions: 131 dysplasia and 119 hyperplasia from two regions of 
Colombia were evaluated. One hundred seventy-four coming from urban area and 104 from a high risk population 
to oral cancer from a rural area. HPV was identified by qPCR and Twenty-four HPVs genotypes were evaluated 
by Luminex® technology. Logistic regressions were performed to establish the associations between HPV infec-
tions with oral dysplasia.
Results: Twenty-eight percent (70/250) of the samples were positives for any HPV and HPV-HRs were more fre-
quently than low risk HPVs. HPV-16 was the most detected genotype (16%) followed by HPV-31, 53, 18 and 45. 
HPV, HPV-HRs and HPV-16 were only associated with dysplasia in urban area; OR 3.28 (CI 95% 1.49-7.17), OR 
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Introduction
While the incidence of cervical cancer has been de-
creasing in industrialized countries, the incidence of 
HPV in oral cavity and oropharynx cancers has been 
increasing over the past 20 years (1,2). An increase of 
the cases of cancers associated to HPV has been report-
ed and a sustained increase of new cases of oropharynx 
squamous cell carcinoma (OPSCC) and oral squamous 
cell carcinoma (OSCC) will be associated with HPV in 
the future (3,4). However, the association between HPV 
and oropharyngeal cancer is much stronger than for oral 
cancer (5) and the association of HPV with OSCC is 
weak and it is still controversial (6).
HPV infection is considered a sexually transmitted dis-
ease, and some sexual practices as lifetime coital sex 
partnership numbers and the number of oral sex part-
ners has been associated with HPV transmission to the 
oral mucosa (7-9) and may increase the risk of HPV-
oral infections and generate important changes in the 
oral epithelium that increase the risk of carcinogenesis 
(10). The viral oncogenes of HPV inactivate two crucial 
human tumor suppressor genes: p53 (E6) and retino-
blastoma protein (pRb) (E7). The inactivation of these 
genes results in loss of cell cycle control, altered cell 
differentiation, increased mutations, and chromosomal 
instability (11,12).
The working group of WHO in 2005 recommended the 
use of the term “oral potentially malignant disorder” 
(OPMD). These lesions refer to an altered epithelium 
with a higher probability of progression to squamous 
cell carcinoma and these changes involve epithelial 
dysplasia (13). However, in 2011, Sarode et al., (14) pro-
posed a novel pathogenesis based classification of OP-
MDs in which all the disorders either carry some risk 
and predispose the oral mucosa to OSCC transforma-
tion and it included lesions such oral leukoplakia and 
conditions as oral lichen planus associated with HPV 
infection (15,16).
Based on their potential oncogenic activity, HPV sub-
types have been divided into high-risk (HPV-HRs) and 
low risk (HPV-LRs) viruses. HPV-HR are associated 
with the development of cancer and are termed onco-
genic viral types (17,18). HPV-HRs 16/18 genotypes 
have been associated with OPSCC, oropharyngeal dys-
plasia (OOPD), OSCC and OPMD-based dysplasia and 
enough evidence supports this association (19,20). OP-
MD-based dysplasia has been compared with normal 
mucosa but the comparison of HPV prevalence in epi-
thelial dysplasia with epithelial hyperplasia is limited. 
HPV-HR having a great affinity for epithelial tissue and 
can penetrate and stay dormant in inflamed tissues such 
as periodontal tissue and can be detected from benign 
oral squamous epithelial lesions (21,22).
More of 100 different genotypes of HPV has been recog-
nized and 15 have been classified as HPV-HRs (23,24). 
Recently, a new technologies for multiple detection of 
HPV genotypes has been development. A new technol-
ogy quantifies simultaneously multiples genotypes us-
ing fluorescent beads, and gene-specific multiplex poly-
merase chain reaction and has been validated for use in 
clinical samples (25).
The purpose of this study is to identify the main gen-
otypes of HPV in oral mucosal lesions according to 
histological changes by comparing lesions with OP-
MD-based dysplasia with those showing hyperplastic 
changes without dysplastic.
Material and Methods
- Type of study
A cross sectional study was realized comparing the 
HPV genotypes in oral lesions with dysplasia and epi-
thelial hyperplasic histologic diagnosis.
- Population
Two hundred and fifty oral mucosal lesions of indi-
viduals diagnosed in different services associated with 
the universities participants of two geographic regions 
of Colombia (Bogotá and the Caribbean region) were 
evaluated. One hundred thirtyone [131] lesions with 
dysplasia and 119 lesions with histologic diagnosis of 
hyperplasia without dysplasia were analyzed to identify 
24 HPV genotypes by the Luminex® technique. One 
hundred twenty-three samples come from Bogota and 
127 come from Caribbean Region.  One hundred forty-
six [146] individuals were evaluated from urban areas 
of the two geographic regions in retrospective and pro-
spective evaluation and the samples were obtained from 
2010 to 2018. A subset of samples [104] obtained in a 
specific high risk to oral cancer population associated 
with the habit of reverse smoking in rural area of Carib-
bean region (Sucre-Department) obtained in 2004 (26) 
also were analyzed.
7.94 (CI 95% 2.97-21.2) and OR 5.90 (CI 95% 2.05-17). Individuals in rural area showed more HPV and HPV-HRs 
infection in hyperplasic lesions than urban population. The majority of HPV+ lesions had multi-type of HPV (52/70) 
and the urban individuals showed more genotypes than rural population. 
Conclusions: HPV-.HRs are frequently found in hyperplastic and dysplastic epithelial lesions. HPV-HRs and HPV-
16 were associated with dysplasia in urban population. Rural high risk population and urban population differ in the 
frequency and variety of HPV genotypes. 
Key words: Human papilloma virus, epithelial dysplasia, epithelial hyperplasia, HPV-genotypes.
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The study was approved by the Ethics Committee of the 
School of Dentistry of Universidad El Bosque (Act. No. 
012-2013). All samples evaluated were obtained with 
informed consent.
- Clinical and socio-demographic data
Socio-demographic data such as age (≤ 45 age/ >45 
years), gender (male/female), region (Bogotá/Carib-
bean), area (rural/urban), date of diagnosis (≤ 5 years/ 
5-10years/ >10 years) were obtained in all samples. Oth-
er data such as cigarette and alcohol consumption could 
not be obtained for all samples because many were ob-
tained from seizures of oral pathology. 
- Selection and exclusion criteria
Clinical diagnoses: Oral lesions not associated with oral 
infections (caries or periodontal disease) were included 
in this study. Lesions from different locations of the oral 
cavity were included, except for lesions of the oropharynx 
and soft palate or lesions of floor of the mouth including 
floor of the tongue. White, red, pigmented and lesions 
without color change such macules, papules, plaques, 
nodules, clinical hyperplasia, ulcers, erosions and blis-
ters, were included for histological analysis. The lesions 
were included if in the histopathological analysis they 
showed a diagnosis of hyperplasia or epithelial dysplasia. 
Histologic diagnoses: expert pathologists evaluated all 
samples in each region. The samples were classified into 
1) with the presence of dysplasia 2) with the presence 
of epithelial hyperplasia without dysplasia. In dyspla-
sia, the cells look abnormal: there are cells of differing 
sizes, misshapen cells, intensely pigmented cells and an 
uncommon number of cells presently dividing, but they 
are not cancer. In hyperplasia, there is an increase in the 
number of cells in an organ or tissue that appear normal 
under a microscope. The basal and para basal hyperpla-
sia were excluded. 
- DNA isolation from paraffin embedded tissue 
To minimize the potential for PCR contamination, the 
histotechnologists were instructed to wear gloves when 
handling blocks and to clean the microtome and the area 
around the cutting station before beginning work, and 
to use a new disposable microtome blade for each block. 
Six serial 5-μm sections were cut from each block. The 
sections were transferred directly from the microtome 
blade into a 1,5mL tube, yielding two tubes per block. 
Total DNA was extracted from the replicate tubes using 
the QIAamp® DNA FFPE Tissue kit (Qiagen, Valencia, 
CA). Briefly, the paraffin was removed by vortexing and 
10 minutes incubation with 1.2 mL xylene, followed by 
two washes with pure (200 proof) ethanol. The air-dried 
pellet was then incubated with 20 μL proteinase K and 
180 μL ATL lysis buffer for 16 hours in a heat block at 
56°C. The lysed emulsion was further purified with the 
DNeasy spin-column kit. DNA was finally recovered in a 
single elution step with 100 μL AE solution from the kit.
- Quality Assessment of DNA and HPV identification
Quality of DNA was confirmed by PCR with primers 
PC03/PC04, which amplify a 110 bp fragment of the ß-
globin gene. The PCR products were visualized by gel 
electrophoresis on 1% agarose gels stained with SYBR 
Safe to identify the amplified 110pb band.  qRT-PCR 
was performed for detection of HPV in samples us-
ing GP5+/GP6+ consensus primers with Kappa SYBR 
Green mastermix kit (Kapa Biosystems®) and CFX96 
Bio-Rad real-time thermal cycler (Biorad, Hercules, 
CA). Briefly, the amplification was performed in 25 μl 
reaction mix containing 0,2µM each of GP5+ and GP6+ 
primers and 30-50ng of genomic DNA in 5 ul of test 
volume. The amplification ramp included first step for 3 
min at 95°C for initial denaturation, followed by dena-
turation cycle of 20 secs at 95°C, an annealing cycle of 
15 secs at 48°C and an elongation and readout cycle of 
30 secs at 72°C for 45 cycles. Genomic DNA from HPV 
positive cells lines CaSki, SiHa and HeLa was used as 
positive controls. The specificity of PCR product was 
verified by a dissociation curve analysis. 
- Multiplex HPV genotyping with Luminex® Technology
The sample DNA extracted from paraffin embedded 
tissue was subjected to PCR amplification, using sets 
of biotinylated BGP5+/BGP6+ primers contained in 
the kit. Additionally, a pair of primers for the ampli-
fication of a ß-globin gene fragment were added to the 
PCR as a control. PCR products were added to the bead 
mix containing 26 distinct bead populations coupled 
to 24 HPV, one ß-globin and one Hybridization Con-
trol specific oligonucleotide probe. The ß-globin con-
trol serves as quality control for genomic DNA in the 
PCR.  After thermal denaturation and hybridization of 
target sequences to the bead-bound probes, labeling of 
the hybridized biotinylated PCR products was achieved 
by R-Phycoerythrin labeled Streptavidin (reporter fluo-
rescence). The beads were analyzed in a Luminex 100 
reader (Luminex Corp.), which uses two lasers, one that 
recognizes the bead set by the internal bead color and 
another to quantify the reporter fluorescence on the 
bead. Based on the detection of specific HPV and ß-
globin PCR products and their combination, the follow-
ing evaluation scheme should be applied (provided that 
usual signal values for the Hybrididization control of 
> 200. For each run and each HPV type a background 
and cut-off value wa scalculated based on the signal of 
the negative control. The kit has a sensitivity of 100% 
(76/76) and specificity of 78.3% (624/797).  The re-
sults were expressed in median fluorescence intensities 
(MIF) of ≥100 beads per sample.
- Statistical analysis 
Descriptive analyses of frequency distribution were 
carried out for all variables. Bivariate analysis was 
performed by chi-square/Fisher tests to establish as-
sociations of the HPV, HPV-HRs, HPV-16, and HPV-
18 with oral dysplasia compared with hyperplasia. All 
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variables of HPV infection which showed a significance 
level <0.10 in the bivariate analysis were included in a 
logistical regression analysis to establish the OR with 
confidence intervals of 95% adjusted to age and gen-
der (Model 1) or adjusted to age, gender, region and 
area (rural/urban) (Model 2). For all logistic models the 
goodness of fit tests for logistic regression (Hosmer-
Lemeshow test) were performed. The models were 
compared with using the likelihood ratio chi-square and 
the Bayesian information criterion (BIC). A multiple 
correspondence analysis was performed to establish the 
correlation between the different genotypes of HPV in 
multiple infections. All data analysis was undertaken 
using Stata (Intercooled v11.0; Stata Corp LP, College 
Station, TX).
Results
- Characteristics of the samples
The samples were mostly lip, palate and oral mucosa 
and with less frequency of tongue and gingiva. One 
hundred and thirty-one had a histological diagnosis of 
dysplasia and 119 were lesions with hyperplasia. The 
lesions most frequently evaluated for both types of his-
tological diagnosis were white lesions, although these 
were more frequent in lesions with dysplasia (54.2% vs. 
32.7%) and most were plaque lesions. The red lesions 
were also frequent but the pigmented lesions were the 
least frequent. Leukoplakia was the most frequent di-
agnosis in both histopathological diagnosis but this was 
more frequent in dysplasia, however, only half of the 
lesions had a presumptive clinical diagnosis (Table 1).
Variable Hyperplasia Dysplasia
P valuen=119 n=131
Frequency (%) Frequency (%)
Localization of lesion 
Lip 27 (24.1) 29 (23.0)
0.198
Tongue 9 (8.0) 5 (4.0)
Alveolar ridge 2 (1.8) 0 (0.0)
Gingiva 12 (31.6) 26 (68.4)
Palate 26 (23.2) 26 (20.6)
Alveolar mucosa 33 (29.5) 34 (27)
Multiples 3 (2.7) 6 (4.8)
Color of the lesion
White lesions 39 (32.7) 71 (54.2)
0.013
Red lesions 29 (24.4) 21 (16)
Pigmented lesion 11 (9.2) 11 (8.4)
Without color changes 34 (28.6) 22 (16.8)
No available 6 (5.0) 6 (4.58)
Type of lesion
Macula 35 (29.4) 22 (16.8)
0.001
Papule 9 (7.6) 16 (12.2)
Plaque 35 (29.4) 68 (51.9)
Nodule 11 (9.2) 4 (3.0)
Hyperplasia 15 (12.6) 12 (9.2)
Ulcer 8 (6.7) 0 (0.0)
Erosion 0 (0.0) 1 (0.8)
Blister 0 (0.0) 2 (1.5)
No available 6 (5.1) 6 (4.6)
Clinical diagnosis
 
Oral Lichen 1 (0.8) 9 (6.9)
0.004
Leucoplakia 21 (17.6) 43 (32.8)
Erythroplakia 1 (0.8) 4 (3.1)
Hyperplasia 5 (4.2) 8 (6.8)
Papilloma 2 (1.7) 0 (0.0)
Reverse smoking 2 (1.7) 1 (0.8)
Hyperkeratosis 2 (1.7) 5 (3.8)
lupus erythematosus 2 (1.7) 1 (0.8)
Undetermined 77 (64.7) 54 (41.2)
No available 6 (5.0) 6 (4.6)
Table 1: Clinical characteristics of the oral lesions.
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- Characteristic of population
The socio demographic and clinic characteristics of the 
lesions evaluated are shown in Table 2. The majority 
of patients were older than 45 years old and women. A 
similar number of samples were evaluated for the two 
regions, although the samples were more from the ur-
ban area.   
- HPV Frequency
70/250 (28%) of the samples were positives for any 
HPV evaluate by qPCR.  The samples HPV+ were most 
frequently in samples with dysplasia than hyperplasia 
(32.8 vs. 22.7%) but the differences were not significant 
(p=0.75). HPV-HRs, HPV-16 and HPV-18 were also 
more frequently identified in dysplasia lesions (Table 
2). HPV, HPV-HRs, HVP-16 and HPV-18 did not show 
significant associations with age nor by gender (female/
male) (HPV; 27% vs., 29%; HPV-16; 17% vs., 16%) 
(p>0.05). (Data not shown). 
- HPV Genotypes
In the majority of the lesions HPV+ analyzed, high-risk 
genotypes were detected. HPV-HRs were more fre-
quently than HPV-LRs. HPV-16 was the most detected 
genotype in all samples and represent 16% of all samples 
analyzed. Other HPV-HRs with an important frequency 
were HPV-31, 18 and 45. HPV-53 showed also an im-
portant frequency but this is not classified in HPV-HRs 
group and has been considered a moderate risk. HPV-11 
was the most frequently HPV-LRs detected (Fig. 1).
Of the all positives genotypes detected, 59/250 (23.6%) 
were HPV-HRs +. HPV-16 was detected in 41/250 
(16.4%), HPV-31 in 21/250 (8.4%), HPV-18, in 15/250 
(6%), HPV-45 in 9/250 (3.6%), and HPV-33, HPV-35 
and HPV-59, in less than 3% of the HPV+ samples. The 
HPV-LRs more frequently were HPV-11 in 9/250 (3.6%) 
and HPV-6 in 8/250 (3.2%). In only three cases the in-
dividuals were infected with one genotype, in the in the 
 
Hyperplasia Dysplasia p value Model 1 Model 2n=119 (%) n=131 (%) OR (CI 95%) OR (CI 95%)
Age  
≤ 45 years 89 (74.7) 96 (73.3)
0.600 ------ ------
> 45 years 30 (25.3) 35 (26.7)
Gender
Male 45 (37.8) 48 (36.6)
0.840 ------ ------
Female 74 (62.2) 83 (63.4)
Region
Bogota 63 (52.9) 60 (45.8)
0.250 ------ ------
Caribbean 56 (47.1) 71 (54.2)
Area
Rural 43 (36.1) 61 (46.6)
0.150 ------ ------
Urban 76 (63.9) 70 (53.4)
HPV 
Negative 92 (77.3) 88 (67.2)
0.075
1.74 0.73
Positive 27 (22.7) 43 (32.8) (0.98 -3.10) (0.31-0.73)
Any HPV High risk
Negative 100 (84) 91 (69.5)
0.007
2.28 0.54
Positive 19 (16) 40 (30.5) (1.22-4.25) (0.22-1.33)
Multiples HPV
Negative 104 (87.4) 97 (74)
0.008
1.48 0.82
Positive 15 (12.6) 34 (26) (1.07-2.05) (0.52-1.28)
HPV 16
Negative 105 (88.2) 104 (79.4)
0.059
2.07 0.46
Positive 14 (11.8) 27 (20.6) (1.02-4.20) (0.15-1.40)
HPV 18
Negative 116 (97.5) 119 (90.8)
0.027
3.79 1.49
Positive 3 (2.5) 12 (9.2) (1.02-13.9) (0.34-6.3)
HPV 16-18
Negative 118 (99.2) 121 (92.4) 0.009
------ ------
Positive 1 (0.8) 10 (7.6)  
Model 1= OR adjusted to age, gender. Model 2= OR adjusted to age, gender, region and area (rural or urban). In all models the likelihood 
ratio chi-square were >0.05 and Bayesian information criterion (BIC) was lower in model 2 and these must be reported.
Table 2: Association of socio-demographic and VPH with dysplastic lesions.
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majority were multiple infections with other HPV-HRs 
viruses. Fifty-two 52/250 (20.8%) lesions showed in-
fections by multiple HPV genotypes. Twenty-two/250 
(8.8%) had infection by two genotypes (4.2% for hyper-
plasia vs. 12.98% for dysplasia) followed by 5 or more 
genotypes 11/250 (2.52% for hyperplasia vs. 6.11% for 
dysplasia). A lower frequency was observed for infec-
tions by 3 and 4 genotypes simultaneously (3.2 for hy-
perplasia vs.  4% for dysplasia).  A multiple correspon-
dence analysis is observed in Fig. 2. HPV 16 showed a 
high co-infection with HPV-HR such as HPV18, 31 and 
45 in samples with dysplasia. In samples with hyper-
plasia, HPV showed co-infection with other HPV-HR 
as HPV 31, 39 and 53 but also with HPV 45 similar to 
dysplasia samples.
- HPV Genotypes in samples with dysplasia and hyper-
plasia
HPVs-HR were more frequently in dysplastic samples 
although they were also detected in hyperplasia.   HPV-
55 and HPV-66 were exclusively detected in samples 
of dysplasia, HPV-42 y HPV-52 only were detected in 
hyperplasia. The HPV-LRs more frequently in hyper-
plasia were HPV-6, HPV-11 (Fig. 3).
Fig. 1: HPV genotypes in dysplastic and hyperplasic lesions.
Fig. 2: A multiple correspondence analysis of HPV geno-
types in dysplasia an epithelial hyperplasia. a)  Dysplasia, b) 
Hyperplasia..
Fig. 3: Comparison of HPV genotypes in dysplasia and hy-
perplasia lesions.
- Association of VPH with dysplastic lesions
Table 2 shows the associations between socio-demo-
graphic factors and the presence of HPV and HPV-HRs 
with lesions of dysplasia compared with lesions of hy-
perplasia. Age, gender, region and area did not show 
significant associations with the presence of dysplasia. 
HPV-HRs and multiple HPV infections showed sig-
nificant associations with dysplasia adjusted to age and 
gender; OR 2.28 (CI 95% 1.22-4.25) and OR 1.48 (CI 
95% 1.07-2.05) respectively. HPV 16, OR 2.07 (CI 95% 
1.02 – 4.20) and HPV 18, OR 3.79 (CI 95% 1.02-13.9), 
were also associated with dysplasia. However, when ad-
justing by area and region, area (rural vs. urban) was 
a potential confounder variable and these associations 
were lost (Table 2).
In Table 3 is observed a stratified analysis for HPV in-
fections for urban and rural samples. HPV presence was 
associated with dysplasia only in urban samples OR 
3.28 (CI 95% 1.49-7.17). HPV-HR also was associated 
in urban samples OR 7.94 (CI 95% 2.97-21.2) and it was 
not significant for rural area OR 0.52 (CI 95% 0.21 – 
1.29). HPV-16 was associated only in urban samples OR 
5.90 (CI 95% 2.05-17) but HPV-18, HPV 18-16 and mul-
tiples infections showed a low frequency in the strata 
and it was not possible to find an accurate association 
with dysplasia in urban or rural samples (Table 3).
- HPV Genotypes in samples with dysplasia and hyper-
plasia in rural and urban samples
Rural population showed more HPV-HRs genotypes 
in hyperplasic samples than urban samples (Fig. 3); 
HPV16, HPV18, HPV 31 showed higher frequencies 
in these samples (Fig. 3). In dysplasia samples urban 
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showed more HPV-HRs genotypes than rural samples 
especially for HPV16, HPV18, HPV 31 and HPV45 (Fig. 
3). Some genotypes such as HPV-42, 55, 66 and HPV-70 
were identified exclusively in samples from urban areas 
and only HPV-52 was detected in rural samples (Fig. 4).
Discussion
The impact of HPV has been investigated in oral cancer 
in the last decades and the association with OPSCC, and 
OSCC has been well established (17,18). The longitu-
dinal studies have not yet shown the predictive value 
of HPV-HR+ in development of oral cancer but a poor 
clearance of E7 antibody associated to HPV-16 are as-
sociated to OPSCC and OSCC recurrence (27,28). As an 
increase in oral cancer associated with HPV has been 
observed, the study of HPV infection in early stages has 
been a focus of attention in recent years (29,30). How-
ever, The HPV association is much stronger in tumors 
of the oropharynx than in oral cancer and the impact of 
HPV in oral cancer is still weak (6,31).
Different studies have suggested that HPV infection is 
probably a potential etiological factor of OPMD (32). 
The term OPMD included an altered epithelium with 
epithelial dysplasia (13). Based on these epithelial 
changes, this study was based on a histological diagno-
sis and not on a clinical diagnosis. Clinical diagnoses 
were lost in retrospective samples and in prospective 
samples some clinical diagnoses such as lichen, leu-
koplakia, erythroplakia and papilloma were included. 
However, other diagnoses but such as hyperplasia and 
hyperkeratosis were also included but do not corre-
spond to a clinical diagnosis. 
In this study, although the presence of high-risk geno-
types was more frequent in lesions with dysplasia in 
urban population, these differences were not observed 
in the rural samples when these were compared with le-
sions with hyperplasia. HPV prevalence varies accord-
ing to different studies and these differences seem to be 
related with sample size, detection methods, geographic 
populations, disease types, and HPV genotypes and it 
 
 
URBAN POPULATION n= 146 RURAL POPULATION n=104




Frequency % Frequency % Frequency % Frequency %
HPV 
Negative 63 (82.9) 43 (61.4) 3.28 29 (67.4) 45 (73.7) 0.73
Positive 13 (17.1) 27 (38.6) (1.49-7.17) 14 (32.6) 16 (26.2) (0.30-1.74)
Any HPV High risk
Negative 70 (92.1) 43 (61.4) 7.94 29 (67.4) 48 (78.7) 0.52
Positive 6 (7.9) 27 (38.6) (2.97-21.2) 14 (32.6) 13 (21.3) (0.21-1.29)
HPV 16
Negative 71 (93.4) 50 (71.4) 5.9 34 (79.1) 54 (88.5) 0.43
Positive 5 (6.6) 20 (28.6) (2.05-17.0) 9 (20.9) 7 (11.5) (0.13-1.33)
OR adjusted to age, gender and region OR adjusted to age and gender
Fig. 4: Comparison of HPV genotypes in rural and urban samples 
in hyperplasia and oral dysplasia. a) Genotypes in urban samples, b) 
Genotypes in rural samples.
Table 3: Association of HPV, HPV-HR, and HPV-16 with dysplastic lesions in a stratified analysis by urban or rural population.
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could be related with the type of control group used (32). 
The prevalence of HPV in cancer-free individuals is 
low and has been reported in 7.7%; healthy patients had 
1.4% of HPV-16 (33). However, in this study individuals 
with oral hyperplasia showed a prevalence of 22.7% of 
HPV-HRs. Oral hyperplasia is a common benign lesion 
of oral mucosa associated to different factors as trauma, 
medications or chronic irritation. Benning lesions such 
to multifocal epithelial hyperplasia, oral papilloma, vul-
garis oral verruca and condyloma acuminatum are as-
sociated to HPV-LR such HPV-6, HPV-11 and HPV-13, 
but the presence of HPV-16 has been reported in a low 
frequency (22). The finding of a significant prevalence 
of HPV-HRs in epithelial hyperplasia could indicate 
that HPV-HRs may be in inflammatory lesions acting 
as reservoirs similar to inflamed gingival pocket epithe-
lium which has been proposed as one of the reservoirs 
of HPV infection (21). However, it is also possible that 
lesions with epithelial hyperplasia are initial lesions of 
HPV-HRs infections and that the persistence of HPV 
can lead to a premalignant lesion.
In rural area the frequency of HPV-HRs was much 
higher than the one observed in urban areas in epithe-
lial hyperplasia. In rural population exist significant 
disparities in knowledge and awareness of HPV and 
the HPV vaccine compared to urban (34). In our rural 
study, it is possible that less information about HPV in-
fection has influenced a greater infection of hyperplasic 
lesions who did not show significant differences with 
dysplasia lesions. These rural samples evaluated in this 
study were included because they belonged to one of 
the participating centers and were obtained from a rural 
area of the Caribbean region with characteristics that 
differ from those obtained from the urban area. This 
population is a high-risk population for oral cancer as-
sociated with the habit of reverse smoking or artisanal 
tobacco (26) and it is possible that this factor combined 
with the sexual behaviors of these population are asso-
ciated with increased HPV infection in oral tissues with 
inflammation. 
The importance of HPV infection in oral epithelia in in-
cipient lesions has focused on oral dysplasia. HPV-HR+ 
have been associated with dysplastic lesions when com-
pared to normal mucous membranes (19). However, few 
studies have evaluated multiple genotypes of HPV in 
these oral mucosal lesions. An important finding in this 
study was that the majority of HPV-positive individuals 
showed multiple genotypes. Although HPV-16 was the 
most frequent genotype, the majority of the patients had 
multi-types associated. Data from 2009-2012 nation-
ally representative sample of United States evaluated 
37 HPV genotypes and the prevalence of multi-type 
(2-6 types) oral HPV infection was and 19.7% (22.0% 
for men, 12.1% for women) in those who had any type 
of oral HPV positivity. In contrast, in this study infec-
tion with multi-type of HPV was only slightly higher 
in men than in women (23% vs. 19%). The risk factors 
for multi-type HPV oral infection were current cigarette 
smoker and having a new sex partner in the past year 
(35). In this study the prevalence of multi-types was 
13% in hyperplasia and 27% in dysplasia, but it was not 
possible to evaluate these factors in all individuals since 
many samples were obtained in pathology banks and 
did not have this information.
HPV-16 was the most important genotype of HPV in hy-
perplasic and dysplastic samples. HPV-16 has been the 
genotype most associated with OPSCC, OOPD, OSCC 
and OPMD followed by HPV-18 (19). In this study 
HPV-18 was not as frequent in the samples analyzed 
and another HPV-HR as HPV-31 was more prevalent. 
In Iranian population HPV-31 has the second genotype 
in frequency after HPV-18 in a study of multiple geno-
types in samples of oral tumors and HPV-16 had a low 
frequency (36). HPV infection seems to be related to 
the geographical regions and a difference in frequency 
and genotypes were observed in rural and urban areas. 
Although the HPV-16 is still the HPV genotype most 
associated with OPSCC, the evidence is not yet conclu-
sive to OSCC by the differences observed in different 
regions (37). Several studies showed that HPV DNA is 
present in a considerable number of OSCC, however, 
the presence of HPV-DNA does not mean the presence 
of a biologically active HPV per se. Further studies 
should be aimed at evaluating markers of viral activity 
by means of E6/E7 and cellular p16INK4A expression 
combined with survival studies (6).
The findings of this study do not support an association 
of HPV with oral epithelial dysplasia compared with 
epithelial hyperplasia because the results vary between 
geographical areas of the same country. The clinical 
significance of high-risk HPV loads in the malignant 
progression of oral potentially malignant disorders 
needs to be clarified. Recently, a retrospective cohort 
of premalignant oral lesions such oral lichen planus and 
dysplasia in Spain population evaluating HPV-DNA 
and p16INK4A expression followed by several years 
did not progress to invasive cancer (38). More studies 
with large population samples are required to confirm 
these findings.
Conclusion
Conclusions   
HPV, HPV-HRs and HPV-16 were more frequent in 
dysplasia lesions only in urban areas.  HPV-16 is the 
most frequently genotype in the lesions evaluated but 
was associated with multi-type infection. HPV geno-
types varies in rural and urban areas.  
- Limitations
One limitation of this study was the lack of healthy oral 
tissue controls by ethics considerations. It was also not 
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possible to obtain comparable samples from the popula-
tion studied to obtain cytological samples to evaluate 
HPV. This study only compares hyperplasia and oral 
dysplasia samples. In this study it was not possible to 
establish associations of HPV with smoking habit be-
cause the information was not available.   Other strong 
limitation of the study was the lack of clinical diagnosis 
in a great number of the cases.
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